Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
For large sums or long-term storage, hardware wallets often win on security. This intro explains when to prefer hardware over mobile.
24,060 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
A new wave of personal AI assistants promises to act before you ask, with Town leading a $55 million round to connect...
When a high-level insider trims a stake, it can spark questions about a company’s near-term prospects. This article b...
April data show the fed's favored inflation gauge rose modestly, keeping inflation well above the 2% target. Analysts...
As volatility in Bitcoin keeps traders on edge, JPMorgan analysts argue that cash may be the stabilizer behind a bitc...
A retirement stress test shows that while buying into Trump Tower is financially possible for some, sustaining the li...
Nu Holdings has fallen sharply, with the stock down 37% from its 52-week high. This guide explains what an investor s...
When a software icon trades at a discount to cash flow, investors ask one simple question: is this a bargain or a tra...
A retiree faces a pivotal choice between VIG and SCHD to anchor a $500,000 dividend strategy. The decision hinges on ...
A well-known consumer stock has faced a sharp sell-off as markets wobble. This guide breaks down why the market punis...
New hiring data arrives as investors weigh whether layoffs to boost efficiency undermine long-term growth. Experts wa...
A former social security commissioner argues for higher taxes on the wealthy to shore up Social Security. The idea so...